Drug Side Effects
Search
IMMUNE RECOVERY UVEITIS
IMMUNE RECOVERY UVEITIS
was reported 58 times
IMMUNE RECOVERY UVEITIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
27
0.0012
1
Rifamycin Antimycobacterial [EPC]
2
0.0006
2
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
8
0.0003
3
Nucleoside Analog Antiviral [EPC]
21
0.0002
4
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
9
0.0001
5
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
8
0.0001
6
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
8
0.0001
7
Tetracycline-class Drug [EPC]
4
0.0001
8
Azole Antifungal [EPC]
8
0.0001
9
Antimetabolite Immunosuppressant [EPC]
1
0.0000
10
Protease Inhibitor [EPC]
1
0.0000
11
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
0.0000
12
Folate Analog Metabolic Inhibitor [EPC]
8
0.0000
13
Cytochrome P450 3A Inhibitor [EPC]
1
0.0000
14
Tumor Necrosis Factor Blocker [EPC]
14
0.0000
15
Corticosteroid [EPC]
14
0.0000
16
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
0.0000
17
CD20-directed Cytolytic Antibody [EPC]
3
0.0000
18
Alkylating Drug [EPC]
2
0.0000
19
Leukocyte Growth Factor [EPC]
1
0.0000
20
Janus Kinase Inhibitor [EPC]
1
0.0000
21
Platinum-based Drug [EPC]
1
0.0000